Catalyst Wire Dossier Catalyst Wire Dossier

Cerebraca Wafer

· Everfront Biotech Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Cerebraca Wafer, covering 2024-09-19 to 2026-01-20. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent Glioblastoma [Phase 2, Phase 3]

See pricing